Nebius Q3: The Bigger Test Is Capital Efficiency, Not Revenue Growth
$NBIS reports tomorrow.
The commercial pipeline is substantial: Microsoft's agreement carries up to $19.4B in value, while Meta's five-year arrangement includes $12B of dedicated capacity and up to $15B of additional compute purchases.
Nebius also raised $5.75B in convertible notes and secured a $3.5B Citi facility.
But the financing terms matter.
The Citi facility matures in 364 days, with an initial spread of SOFR + 275 bps. Meanwhile, the Microsoft contract ties revenue to actual GPU deployment and availability.
Nebius has demonstrated access to customers and capital. The remaining question is how efficiently it converts both into operating assets.
For Q3, I'd watch three numbers beyond revenue:
Incremental revenue-generating GPU capacity.
Customer prepayments versus cash capex and new borrowing.
Depreciation and financing costs relative to operating cash generation.
A revenue beat would be encouraging. But higher guidance supported by faster deployments and better funding economics would tell us much more.
For Nebius, the next valuation driver may be less about how much compute it sells—and more about how much shareholder capital it takes to deliver it.
#stocks
$NBIS.US
$NBIS reports tomorrow.
The commercial pipeline is substantial: Microsoft's agreement carries up to $19.4B in value, while Meta's five-year arrangement includes $12B of dedicated capacity and up to $15B of additional compute purchases.
Nebius also raised $5.75B in convertible notes and secured a $3.5B Citi facility.
But the financing terms matter.
The Citi facility matures in 364 days, with an initial spread of SOFR + 275 bps. Meanwhile, the Microsoft contract ties revenue to actual GPU deployment and availability.
Nebius has demonstrated access to customers and capital. The remaining question is how efficiently it converts both into operating assets.
For Q3, I'd watch three numbers beyond revenue:
Incremental revenue-generating GPU capacity.
Customer prepayments versus cash capex and new borrowing.
Depreciation and financing costs relative to operating cash generation.
A revenue beat would be encouraging. But higher guidance supported by faster deployments and better funding economics would tell us much more.
For Nebius, the next valuation driver may be less about how much compute it sells—and more about how much shareholder capital it takes to deliver it.
#stocks
$NBIS.US